Rapt Therapeutics Inc (NASDAQ:RAPT)
| 20.89 Delayed Data As of Jan 15 |  -0.16 / -0.76%Today’s Change | 10.52 Today|||52-Week Range 51.21 | +5.77% Year-to-Date |
Latest RAPT News | Press Releases
No recent news for Rapt Therapeutics Inc.
Today’s Trading
| Previous close | 21.05 |
| Today’s open | 21.05 |
| Day’s range | 20.63 - 21.44 |
| Volume | 5,458 |
| Average volume (3 months) | 387,061 |
| Market cap | $513.0M |
Data as of 3:59pm ET, 01/15/2021
Growth & Valuation
| Earnings growth (last year) | -15.94% |
| Earnings growth (this year) | +77.85% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | 0.7 |
| Price/Sales | -- |
| Price/Book | 6.24 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GERNGeron Corp | -0.05 | -2.65% |
| FBRXForte Biosciences In... | +1.21 | +3.19% |
| SURFSurface Oncology Inc | +0.32 | +2.68% |
| APLTApplied Therapeutics... | -0.08 | -0.37% |
Data as of 4:00pm ET, 01/15/2021
Financials
| Next reporting date | April 5, 2021 |
| EPS forecast (this quarter) | -$0.58 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$43.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
